Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland

原发性甲状旁腺功能亢进 医学 入射(几何) 人口 记录链接 甲状旁腺切除术 儿科 回顾性队列研究 流行病学 人口学 内科学 甲状旁腺激素 环境卫生 光学 物理 社会学
作者
Enrique Soto‐Pedre,Paul Newey,Graham Leese
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [The Endocrine Society]
卷期号:108 (10): e1117-e1124 被引量:15
标识
DOI:10.1210/clinem/dgad201
摘要

Previous studies, including our own, have demonstrated a highly variable incidence of primary hyperparathyroidism (PHPT) from year to year.We planned to provide a current estimate of the incidence and prevalence of PHPT in a community-based study.A population-based retrospective follow-up study was conducted in Tayside (Scotland) from 2007 to 2018. Record-linkage technology (demography, biochemistry, prescribing, hospital admissions, radiology, and mortality data) was used to identify all patients. Cases of PHPT were defined as those with at least 2 raised serum corrected calcium concentration CCA (> 2.55 mmol/L) and/or hospital admissions with PHPT diagnoses and/or surgery records with parathyroidectomy during the follow-up period. The number of prevalent and incident cases of PHPT per calendar year by age and sex were estimated.A total of 2118 people (72.3% female, mean age 65 years) were identified with an incident case of PHPT. The overall prevalence of PHPT over the 12 years of the study was 0.84% (95% CI, 0.68%-1.02%), steadily increasing from 0.71% in 2007 to 1.02% in 2018. From 2008, the incidence of PHPT was relatively stable from 4 to 6 cases per 10 000 person-years, declining from 11.5 per 10 000 person-years in 2007. The incidence varied from 0.59 per 10 000 person-years (95% CI, 0.40%-0.77%) for those aged 20 to 29 years, to 12.4 per 10 000 person-years (95% CI, 11.2%-13.3%) in those aged 70 to 79 years. Incidence of PHPT was 2.5 times higher in women than in men.This study is the first showing a relatively steady annual incidence of PHPT at 4 to 6 per 10 000 person-years. This population-based study reports a PHPT prevalence of 0.84%.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
乔qiao发布了新的文献求助30
3秒前
WZ0904发布了新的文献求助10
4秒前
poegtam完成签到,获得积分10
5秒前
大胆盼兰发布了新的文献求助10
6秒前
wuyan204完成签到 ,获得积分10
7秒前
windcreator完成签到,获得积分10
7秒前
redondo5完成签到,获得积分0
7秒前
wangrswjx完成签到 ,获得积分10
7秒前
科研通AI5应助su采纳,获得10
7秒前
10秒前
12秒前
小二郎应助嘻嘻采纳,获得10
12秒前
yun完成签到 ,获得积分10
13秒前
13秒前
15秒前
健忘曼冬发布了新的文献求助10
15秒前
redondo完成签到,获得积分10
15秒前
momo完成签到,获得积分10
16秒前
希望天下0贩的0应助meng采纳,获得10
17秒前
龙歪歪发布了新的文献求助10
18秒前
18秒前
暮城完成签到,获得积分10
18秒前
19秒前
云墨完成签到 ,获得积分10
19秒前
21秒前
22秒前
Akim应助caoyy采纳,获得10
22秒前
23秒前
科研通AI2S应助DreamMaker采纳,获得10
23秒前
26秒前
zho发布了新的文献求助30
26秒前
26秒前
ywang发布了新的文献求助10
26秒前
ZD小草完成签到 ,获得积分10
27秒前
健忘曼冬完成签到,获得积分10
28秒前
hkl1542发布了新的文献求助50
29秒前
30秒前
31秒前
KYN完成签到,获得积分10
32秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527998
求助须知:如何正确求助?哪些是违规求助? 3108225
关于积分的说明 9288086
捐赠科研通 2805889
什么是DOI,文献DOI怎么找? 1540195
邀请新用户注册赠送积分活动 716950
科研通“疑难数据库(出版商)”最低求助积分说明 709849